Search

Quanterix Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

3.24 1.89

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.16

Max

3.27

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-31M

-49M

Pardavimai

-3.5M

33M

Pelnas, tenkantis vienai akcijai

-0.45

Pelno marža

-148.708

Darbuotojai

450

EBITDA

-38M

-49M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

-8.26% downside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

30M

144M

Ankstesnė atidarymo kaina

1.35

Ankstesnė uždarymo kaina

3.24

Naujienos nuotaikos

By Acuity

16%

84%

12 / 339 reitingas Healthcare

Quanterix Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-25 22:50; UTC

Quanterix Corp declined significantly in after-market trading, reversing a slight earlier gain, yet remains above its 20-day moving average and near its one-month range.

2026-09-24 20:07; UTC

Quanterix Corp's shares traded roughly flat, remaining near unchanged since Wednesday's close while positioned above its 20-day moving average.

2026-09-18 19:46; UTC

Quanterix Corp shares fell notably during Friday's trading session, with a significant decline around midday before partially recovering, remaining above the 20-day moving average.

2026-09-17 20:02; UTC

News

Quanterix Corp announced inducement grants totaling 625.64k restricted stock units, contributing to heightened investor interest as shares trade sharply higher.

2026-09-16 21:11; UTC

Quanterix Corp is advancing in after-market trading, reflecting a modest increase since Wednesday's close and maintaining a trend of three consecutive higher daily closes.

2026-09-15 20:01; UTC

Quanterix Corp shares are higher during Tuesday's session, maintaining positive momentum despite a broader market decline tied to the NY Empire State Manufacturing Index.

2026-09-14 20:03; UTC

News

Quanterix Corp appointed Dr. Yuri Fesko as Chief Medical Officer, yet shares are trading lower amid ongoing performance weakness.

2026-09-11 19:26; UTC

Quanterix Corp shares are higher amid market response to steady inflation data. Earlier, the stock pulled back from a session high before regaining momentum.

2026-09-10 20:07; UTC

Quanterix Corp shares are lower today, pressured by broader market conditions following the European Central Bank's interest rate hike.

2026-09-09 20:07; UTC

Quanterix Corp shares are lower today, reaching a session low amid ongoing weakness and trading near the lower end of their one-month range.

2026-09-08 20:07; UTC

Quanterix Corp shares are higher today, reflecting broader market dynamics amid speculation over a potential Federal Reserve interest rate hike.

2026-09-04 20:08; UTC

Quanterix Corp shares are higher today, continuing a strong upward trend since Thursday's close, despite broader market pressures from a strong jobs report.

2026-09-03 20:07; UTC

Quanterix Corp shares are lower today, continuing a decline since Wednesday. The stock is near the lower end of its one-month range.

2026-09-02 19:46; UTC

Quanterix Corp shares are higher today, though still below their 20-day moving average. Broader market conditions are affected by rising U.S. Treasury yields.

2026-09-01 20:01; UTC

Quanterix Corp shares are lower today, continuing a decline since Monday. Broader market concerns include rising oil prices and inflation expectations.

2026-08-31 19:16; UTC

Quanterix Corp shares are lower amid market anxiety following hawkish remarks from Federal Reserve Chair Kevin Warsh on potential interest rate hikes.

2026-08-28 23:41; UTC

Quanterix Corp shares are lower in after-market trading, following a decline earlier in the session amid rising U.S. Treasury yields and falling tech stocks.

2026-08-24 20:02; UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

2026-08-22 00:02; UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

2026-08-20 20:06; UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

2026-08-19 22:31; UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

2026-08-18 23:06; UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

2026-08-17 20:01; UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

2026-08-14 23:01; UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

2026-08-13 20:02; UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

2026-08-12 23:01; UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

2026-08-11 22:51; UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

2026-08-10 19:51; UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

2026-08-07 19:16; UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

2026-08-05 19:23; UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Quanterix Corp Prognozė

Kainos tikslas

By TipRanks

-8.26% į apačią

12 mėnesių prognozė

Vidutinis 3 USD  -8.26%

Aukščiausias 3 USD

Žemiausias 3 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Quanterix Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

2 ratings

0

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

12 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.